Shandong Xinhua Pharmaceutical Co., Ltd

Hualu Network Group 中文版

Investor Relation

Information transparency and trust in peers

Investor Relation

INTERIM REPORT

Overseas Regulatory Announcement-Announcement on Ibuprofen Suspension Drops Having Obtained Drug Registration Certificate

Overseas Regulatory Announcement-Announcement on Ibuprofen Suspension Drops Having Obtained Drug Registration Certificate

Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs

Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Overseas Regulatory Announcement-Announcement on Aminophylline Tablets Passing the Generic Drugs Consistency Evaluation

Announcement Notice of Board Meeting

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2025

总条数: 16条

＜ 1 2 ＞

跳转到: 页